Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2017

01-01-2017 | Original Article

Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma

Authors: Chunsun Li, Miaomiao Wu, Guijuan Zong, Chunhua Wan, Qingqing Liu, Huiling Zhou, Lu Hua, Yuyan Chen, Xudong Chen, Cuihua Lu

Published in: Digestive Diseases and Sciences | Issue 1/2017

Login to get access

Abstract

Background

Protein phosphatase 1γ (PP1γ), as a member of the protein phosphatase 1 family, may be involved in regulation of multiple cellular processes, such as mitosis, cell survival, and apoptosis. However, little is known about the underlying mechanisms by which PP1γ regulates hepatocellular carcinoma development.

Aim

We investigated the expression profile of PP1γ in hepatocellular carcinoma (HCC) cell lines and human HCC specimens, as well as its potential prognostic significance in HCC.

Methods

PP1γ expression profile was detected in 94 HCC specimens using immunohistochemistry. PP1γ levels in HCC cells were downregulated by small interfering RNA (siRNA) transfection. Cell cycle progression and proliferation status of HCC cells and the effectiveness of doxorubicin were evaluated by flow cytometry and CCK-8 assay. The levels of PP1γ, CyclinD1, PCNA, Mdmx, p53, p21, and active caspase-3 were evaluated by Western blot analysis.

Results

PP1γ was upregulated in tumorous specimens, compared with adjacent nontumorous tissues. Univariate and multivariate survival analyses were conducted to determine the prognostic significance of PP1γ in HCC. The expression pattern of PP1γ was positively correlated with tumor size, histological grade, Ki-67 expression, and poor prognosis in HCC. In addition, depletion of PP1γ by siRNA could inhibit cell proliferation, resulted in G1 phase arrest, and attenuated resistance to doxorubicin in Huh7 cells.

Conclusions

PP1γ is upregulated in HCC cell lines and HCC specimens, promotes cancer cell proliferation through regulation of p53, and may be a potential target for treatment of HCC.
Literature
1.
go back to reference Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150:835–853.CrossRefPubMed Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150:835–853.CrossRefPubMed
2.
go back to reference Zhang X, Ng HL, Lu A, et al. Drug delivery system targeting advanced hepatocellular carcinoma: current and future. Nanomed Nanotechnol Biol Med. 2016;12:853–869.CrossRef Zhang X, Ng HL, Lu A, et al. Drug delivery system targeting advanced hepatocellular carcinoma: current and future. Nanomed Nanotechnol Biol Med. 2016;12:853–869.CrossRef
3.
go back to reference Cohen PT. Protein phosphatase 1—targeted in many directions. J Cell Sci. 2002;115:241–256.PubMed Cohen PT. Protein phosphatase 1—targeted in many directions. J Cell Sci. 2002;115:241–256.PubMed
4.
go back to reference Comerford KM, Leonard MO, Cummins EP, et al. Regulation of protein phosphatase 1gamma activity in hypoxia through increased interaction with NIPP1: implications for cellular metabolism. J Cell Physiol. 2006;209:211–218.CrossRefPubMed Comerford KM, Leonard MO, Cummins EP, et al. Regulation of protein phosphatase 1gamma activity in hypoxia through increased interaction with NIPP1: implications for cellular metabolism. J Cell Physiol. 2006;209:211–218.CrossRefPubMed
5.
go back to reference Trinkle-Mulcahy L, Andersen J, Lam YW, Moorhead G, Mann M, Lamond AI. Repo-MAN recruits PP1 gamma to chromatin and is essential for cell viability. J Cell Biol. 2006;172:679–692.CrossRefPubMedPubMedCentral Trinkle-Mulcahy L, Andersen J, Lam YW, Moorhead G, Mann M, Lamond AI. Repo-MAN recruits PP1 gamma to chromatin and is essential for cell viability. J Cell Biol. 2006;172:679–692.CrossRefPubMedPubMedCentral
6.
go back to reference Vietri M, Bianchi M, Ludlow JW, Mittnacht S, Villa-Moruzzi E. Direct interaction between the catalytic subunit of protein phosphatase 1 and pRb. Cancer Cell Int. 2006;6:3.CrossRefPubMedPubMedCentral Vietri M, Bianchi M, Ludlow JW, Mittnacht S, Villa-Moruzzi E. Direct interaction between the catalytic subunit of protein phosphatase 1 and pRb. Cancer Cell Int. 2006;6:3.CrossRefPubMedPubMedCentral
7.
go back to reference Lu Z, Wan G, Guo H, Zhang X, Lu X. Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx. Cell Signal. 2013;25:796–804.CrossRefPubMed Lu Z, Wan G, Guo H, Zhang X, Lu X. Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx. Cell Signal. 2013;25:796–804.CrossRefPubMed
8.
go back to reference Theurillat JP, Metzler SC, Henzi N, et al. URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell. 2011;19:317–332.CrossRefPubMed Theurillat JP, Metzler SC, Henzi N, et al. URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell. 2011;19:317–332.CrossRefPubMed
9.
go back to reference Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors. BMC Cancer. 2007;7:85.CrossRefPubMedPubMedCentral Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors. BMC Cancer. 2007;7:85.CrossRefPubMedPubMedCentral
10.
go back to reference Jiang D, Hu B, Wei L, et al. High expression of vacuolar protein sorting 4B (VPS4B) is associated with accelerated cell proliferation and poor prognosis in human hepatocellular carcinoma. Pathol Res Pract. 2015;211:240–247.CrossRefPubMed Jiang D, Hu B, Wei L, et al. High expression of vacuolar protein sorting 4B (VPS4B) is associated with accelerated cell proliferation and poor prognosis in human hepatocellular carcinoma. Pathol Res Pract. 2015;211:240–247.CrossRefPubMed
11.
go back to reference Bao Z, Duan C, Gong C, et al. Protein phosphatase 1gamma regulates the proliferation of human glioma via the NF-kappaB pathway. Oncol Rep. 2016;35:2916–2926.PubMed Bao Z, Duan C, Gong C, et al. Protein phosphatase 1gamma regulates the proliferation of human glioma via the NF-kappaB pathway. Oncol Rep. 2016;35:2916–2926.PubMed
12.
go back to reference Wan C, Hou S, Ni R, et al. MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability. Oncogene. 2015;34:237–245.CrossRefPubMed Wan C, Hou S, Ni R, et al. MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability. Oncogene. 2015;34:237–245.CrossRefPubMed
13.
go back to reference Zhang S, Shi W, Chen Y, et al. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma. Mol Cell Biochem. 2015;410:1–9.CrossRefPubMed Zhang S, Shi W, Chen Y, et al. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma. Mol Cell Biochem. 2015;410:1–9.CrossRefPubMed
14.
go back to reference Li Y, Jenkins CW, Nichols MA, Xiong Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene. 1994;9:2261–2268.PubMed Li Y, Jenkins CW, Nichols MA, Xiong Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene. 1994;9:2261–2268.PubMed
15.
go back to reference Fornari F, Gramantieri L, Giovannini C, et al. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2009;69:5761–5767.CrossRefPubMed Fornari F, Gramantieri L, Giovannini C, et al. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2009;69:5761–5767.CrossRefPubMed
16.
go back to reference Rampone B, Schiavone B, Martino A, Viviano C, Confuorto G. Current management strategy of hepatocellular carcinoma. World J Gastroenterol. 2009;15:3210–3216.CrossRefPubMedPubMedCentral Rampone B, Schiavone B, Martino A, Viviano C, Confuorto G. Current management strategy of hepatocellular carcinoma. World J Gastroenterol. 2009;15:3210–3216.CrossRefPubMedPubMedCentral
18.
go back to reference Opaluch AM, Schneider M, Chiang CY, et al. Positive regulation of TRAF6-dependent innate immune responses by protein phosphatase PP1-gamma. PLoS ONE. 2014;9:e89284.CrossRefPubMedPubMedCentral Opaluch AM, Schneider M, Chiang CY, et al. Positive regulation of TRAF6-dependent innate immune responses by protein phosphatase PP1-gamma. PLoS ONE. 2014;9:e89284.CrossRefPubMedPubMedCentral
19.
20.
go back to reference Mitsuhashi S, Shima H, Tanuma N, et al. Usage of tautomycetin, a novel inhibitor of protein phosphatase 1 (PP1), reveals that PP1 is a positive regulator of Raf-1 in vivo. J Biol Chem. 2003;278:82–88.CrossRefPubMed Mitsuhashi S, Shima H, Tanuma N, et al. Usage of tautomycetin, a novel inhibitor of protein phosphatase 1 (PP1), reveals that PP1 is a positive regulator of Raf-1 in vivo. J Biol Chem. 2003;278:82–88.CrossRefPubMed
21.
go back to reference Djouder N, Metzler SC, Schmidt A, et al. S6K1-mediated disassembly of mitochondrial URI/PP1gamma complexes activates a negative feedback program that counters S6K1 survival signaling. Mol Cell. 2007;28:28–40.CrossRefPubMed Djouder N, Metzler SC, Schmidt A, et al. S6K1-mediated disassembly of mitochondrial URI/PP1gamma complexes activates a negative feedback program that counters S6K1 survival signaling. Mol Cell. 2007;28:28–40.CrossRefPubMed
22.
go back to reference Tummala KS, Gomes AL, Yilmaz M, et al. Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage. Cancer Cell. 2014;26:826–839.CrossRefPubMed Tummala KS, Gomes AL, Yilmaz M, et al. Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage. Cancer Cell. 2014;26:826–839.CrossRefPubMed
23.
go back to reference Wang X, Simpson ER, Brown KA. p53: protection against tumor growth beyond effects on cell cycle and apoptosis. Cancer Res. 2015;75:5001–5007.CrossRefPubMed Wang X, Simpson ER, Brown KA. p53: protection against tumor growth beyond effects on cell cycle and apoptosis. Cancer Res. 2015;75:5001–5007.CrossRefPubMed
24.
go back to reference Shen HM, Ong CN. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis. Mutat Res. 1996;366:23–44.CrossRefPubMed Shen HM, Ong CN. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis. Mutat Res. 1996;366:23–44.CrossRefPubMed
Metadata
Title
Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma
Authors
Chunsun Li
Miaomiao Wu
Guijuan Zong
Chunhua Wan
Qingqing Liu
Huiling Zhou
Lu Hua
Yuyan Chen
Xudong Chen
Cuihua Lu
Publication date
01-01-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4365-1

Other articles of this Issue 1/2017

Digestive Diseases and Sciences 1/2017 Go to the issue

Stanford Multidisciplinary Seminars

Pulmonary Crohn’s Disease

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.